Fuente: Business Insider
Cava's CEO said weight-loss drugs are fuelling the rise of a "big kids" market. Dixie D. Vereen/For The Washington Post via Getty ImagesDiners on GLP-1 drugs are increasingly opting for kids' meals, said Cava CEO Brett Schulman.
Leer en la Fuente
Noticias Relacionadas